Qianjin Pharmaceutical Industry: Net profit in the first half of 2025 increased by 8.50% year-on-year.

Qianjin Pharmaceutical announced that its operating income in the first half of 2025 was 1.818 billion yuan, a year-on-year decrease of 5.52%. Net profit was 128 million yuan, a year-on-year increase of 8.50%. Basic earnings per share were 0.3012 yuan per share, a year-on-year increase of 8.46%.